S.M.A.R.T. (Students Motivating and Acting in Real-Time) eStudy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Healthy Subject
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Enrollment
- 101
- Locations
- 1
- Primary Endpoint
- Receipt of the first dose of HPV vaccine in intervention and control group
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
This randomized pilot trial studies how well a mobile health (mHealth) intervention works in increasing human papillomavirus (HPV) vaccination among college students at the Ohio State University. mHealth educational intervention may communicate information about HPV vaccination and increase HPV vaccine uptake in college students.
Detailed Description
PRIMARY OBJECTIVES: I. Pilot test an mHealth HPV vaccine intervention for college students to establish feasibility and acceptability. II. Obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group. SECONDARY OBJECTIVES: I. Examine whether the mHealth HPV vaccine intervention affects secondary outcomes compared to the control group. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message. ARM II: Participants receive standard information about HPV and then HPV vaccine information statement (VIS) via the mobile-friendly website. After completion of study, participants are followed up at 3 and 7 months.
Investigators
Mira Katz
Principal Investigator
Ohio State University Comprehensive Cancer Center
Eligibility Criteria
Inclusion Criteria
- •Currently enrolled as a first year Ohio State University (OSU) student on the Columbus campus
- •Being able to read English
- •Not having received any doses of the HPV vaccine
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Receipt of the first dose of HPV vaccine in intervention and control group
Time Frame: Up to 7 months
Will obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group.
Participant satisfaction scores
Time Frame: Up to 7 months
Acceptability and feasibility will be established by examining participant satisfaction with study materials.